Navigation Links
American Pacific to Release Financial Results and Hold Fiscal 2008 Third Quarter Investor Teleconference
Date:7/29/2008

LAS VEGAS, July 29 /PRNewswire-FirstCall/ -- American Pacific Corporation (Nasdaq: APFC) today announced that it will release its Fiscal 2008 third quarter financial results on Tuesday, August 5, 2008. John R. Gibson, Chairman and Chief Executive Officer, invites you to participate in a teleconference to review the financial results and outlook of the Company.

The teleconference will be held Tuesday, August 5, 2008 at 1:30 p.m. PDT. To access the call please dial (973) 582-2852 and reference conference ID #58118598. Following a short presentation by Mr. Gibson and Dana M. Kelley, Vice President, Chief Financial Officer and Treasurer, there will be a Q&A session. Also present on the call will be Joseph Carleone, President and Chief Operating Officer.

The teleconference will be simultaneously webcast via Thomson Financial's First Call Events. A link to the live webcast will be available at the Company's website at http://www.apfc.com and will remain available for replay through December 2008.

American Pacific is a leading manufacturer of specialty and fine chemicals within its focused markets, as well as propulsion products sold to defense, aerospace and pharmaceutical end markets. Our products provide access to, and movement in, space via solid fuel and propulsion thrusters and represent the key active ingredient in drug applications such as HIV, epilepsy and cancer. We also produce specialty chemicals utilized in various applications such as fire extinguishing systems, as well as manufacture water treatment equipment. Our products are designed to meet customer specifications and often must meet certain governmental and regulatory approvals. Additional information about American Pacific can be obtained by visiting the Company's web site at http://www.apfc.com.


'/>"/>
SOURCE American Pacific Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Cepheid Introduces GeneXpert(R) Infinity-48 System at 2008 American Association of Clinical Chemistry Meeting
2. American Oriental Bioengineering, Inc. to Report Second Quarter 2008 Financial Results
3. Pennsylvania Governor Rendell Breaks Ground for Global Pharmaceutical Services Companys North American Headquarters
4. American Oriental Bioengineering Proposes Offering of $85 Million of Convertible Notes
5. American Telugu Association's Convention Attracts Over 10,000 People in the U.S.
6. Covert Torture, Surveillance Jeopardizes the Freedom of American Citizens
7. TorreyPines Therapeutics to Present Tezampanel Phase IIb Clinical Data for Acute Migraine at 50th Annual Scientific Meeting of the American Headache Society
8. 17th Annual Congress on Womens Health To Be Held March 27-29, 2009 in Collaboration with American Medical Womens Association (AMWA)
9. Ten Latin American Scientists Named 2008 Pew Fellows in the Biomedical Sciences
10. American Oriental Bioengineering Appoints Anindya Chatterjee to Chief Strategy Officer
11. American Oriental Bioengineering Announces that it Withdraws Convertible Preferred Stock Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... June 27, 2016  Global demand for enzymes ... through 2020 to $7.2 billion.  This market includes ... cleaning products, biofuel production, animal feed, and other ... and biocatalysts). Food and beverages will remain the ... increasing consumption of products containing enzymes in developing ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... medical technologies, services and solutions to the healthcare market. The company's primary focus ... distribution, manufacturing, sales and marketing strategies that are necessary to help companies efficiently ...
(Date:6/24/2016)... DIEGO , June 24, 2016 ... more sensitively detects cancers susceptible to PARP inhibitors ... circulating tumor cells (CTCs). The new test has ... HRD-targeted therapeutics in multiple cancer types. ... targeting DNA damage response pathways, including PARP, ATM, ...
(Date:6/23/2016)... 23, 2016   Boston Biomedical , an ... designed to target cancer stemness pathways, announced that ... Orphan Drug Designation from the U.S. Food and ... cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin is ... inhibit cancer stemness pathways by targeting STAT3, and ...
Breaking Biology Technology:
(Date:6/2/2016)...   The Weather Company , an IBM Business (NYSE: ... capability in which consumers will be able to interact with ... via voice or text and receive relevant information about the ... Marketers have long sought an advertising solution that can create ... relevant and valuable; and can scale across millions of interactions ...
(Date:5/16/2016)... May 16, 2016   EyeLock LLC , a ... the opening of an IoT Center of Excellence in ... expand the development of embedded iris biometric applications. ... of convenience and security with unmatched biometric accuracy, making ... aside from DNA. EyeLock,s platform uses video technology to ...
(Date:4/28/2016)... First quarter 2016:   , ... the first quarter of 2015 The gross margin was ... 18.8) and the operating margin was 40% (-13) Earnings ... flow from operations was SEK 249.9 M (21.2) , ... SEK 7,000-8,500 M. The operating margin for 2016 is ...
Breaking Biology News(10 mins):